Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

ClinicalTrials.gov ID: NCT07509151

Public ClinicalTrials.gov record NCT07509151. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 9, 2026, 5:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomised, Open-label, Multicentre, Study of Surovatamig as Consolidation Therapy Versus Observation After First-line Induction Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV (SOUNDTRACK-C1)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the therapeutic benefit and safety of subcutaneous (SC) Surovatamig monotherapy as consolidation therapy in patients with Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) with unmutated IGHV (uIGHV).

Study identification

NCT ID: NCT07509151
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: AstraZeneca; Industry
Enrollment: 420 participants

Conditions and interventions

Conditions

Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV

Interventions

Surovatamig Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 18 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 4, 2026
Primary completion: Aug 28, 2031
Completion: Apr 4, 2032
Last update posted: Sep 7, 2026

2026 – 2032

United States locations

U.S. sites: 14
U.S. states: 14
U.S. cities: 14

Facility	City	State	ZIP	Site status
Research Site	La Jolla	California	92093	Not yet recruiting
Research Site	Denver	Colorado	80218	Not yet recruiting
Research Site	New Haven	Connecticut	06510	Not yet recruiting
Research Site	Chicago	Illinois	60637	Not yet recruiting
Research Site	Kansas City	Kansas	66210	Not yet recruiting
Research Site	Louisville	Kentucky	40207	Not yet recruiting
Research Site	Bethesda	Maryland	20817	Not yet recruiting
Research Site	Boston	Massachusetts	02215	Not yet recruiting
Research Site	Rochester	Minnesota	55905	Not yet recruiting
Research Site	Basking Ridge	New Jersey	07920	Not yet recruiting
Research Site	Rochester	New York	14642	Not yet recruiting
Research Site	Cleveland	Ohio	44195	Not yet recruiting
Research Site	Pittsburgh	Pennsylvania	15232	Not yet recruiting
Research Site	Houston	Texas	77030	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07509151, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 7, 2026 · Synced Sep 9, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07509151 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →